LIPRIDIA Trademark

Trademark Overview

On Friday, May 31, 2013, a trademark application was filed for LIPRIDIA with the United States Patent and Trademark Office. The USPTO has given the LIPRIDIA trademark a serial number of 85947703. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 30, 2017. This trademark is owned by Cadila Healthcare Ltd.. The LIPRIDIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of Diabetes, Dyslipidemia, NASH, Hypertriglycedemia and HIV-induced lipodystrophy
lipridia

General Information

Serial Number85947703
Word MarkLIPRIDIA
Filing DateFriday, May 31, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 30, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 29, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in the treatment of Diabetes, Dyslipidemia, NASH, Hypertriglycedemia and HIV-induced lipodystrophy

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 11, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCadila Healthcare Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGujarat
IN
Party NameCadila Healthcare Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGujarat
IN

Trademark Events

Event DateEvent Description
Monday, January 30, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 30, 2017ABANDONMENT - NO USE STATEMENT FILED
Saturday, July 2, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 1, 2016EXTENSION 5 GRANTED
Thursday, June 16, 2016EXTENSION 5 FILED
Thursday, June 16, 2016TEAS EXTENSION RECEIVED
Wednesday, November 25, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 24, 2015EXTENSION 4 GRANTED
Wednesday, November 18, 2015EXTENSION 4 FILED
Wednesday, November 18, 2015TEAS EXTENSION RECEIVED
Friday, July 3, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 2, 2015EXTENSION 3 GRANTED
Monday, June 15, 2015EXTENSION 3 FILED
Monday, June 15, 2015TEAS EXTENSION RECEIVED
Tuesday, February 17, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 16, 2015EXTENSION 2 GRANTED
Tuesday, December 16, 2014EXTENSION 2 FILED
Thursday, February 12, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 16, 2014TEAS EXTENSION RECEIVED
Friday, June 13, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 11, 2014EXTENSION 1 GRANTED
Wednesday, June 11, 2014EXTENSION 1 FILED
Wednesday, June 11, 2014TEAS EXTENSION RECEIVED
Thursday, April 3, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 24, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 29, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 29, 2013PUBLISHED FOR OPPOSITION
Wednesday, October 9, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, September 16, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, September 16, 2013ASSIGNED TO EXAMINER
Tuesday, June 11, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, June 4, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

lipridia hypertriglycedemia induced lipodystrophy nash dyslipidemia preparations treatment diabetes pharmaceutical